Baxter Healthcare Corp (Baxter Healthcare) is a pharmaceutical company that delivers products and services which are essential building blocks of healthcare. The company carries out the developing, manufacturing and marketing healthcare equipment and instruments for the treatment of hemophilia, kidney disease, trauma, immune disorders, infectious disease, chronic and acute medical conditions. It applies its expertise in pharmaceuticals, medical devices and biotechnology to create products, which improve patient care worldwide. Baxter Healthcare is headquartered in Deerfield, Illinois, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Baxter Healthcare Corp
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Baxter Healthcare Corp Company Overview
Baxter Healthcare Corp Company Snapshot
Baxter Healthcare Corp Pipeline Products and Ongoing Clinical Trials Overview
Baxter Healthcare Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Baxter Healthcare Corp, Recent Developments
Nov 30, 2023: Baxter Issues Urgent Medical Device Correction for Novum IQ Syringe Infusion Pump Due to Potential Impact of Downstream Occlusions on Infusion Volume
Sep 28, 2023: Baxter Healthcare Obtains 510(k) Clearance for CleanCart A
Sep 28, 2023: Baxter Healthcare Obtains 510(k) Clearance for CleanCart C
Table 14: Novum IQ Large Volume Pump - Product Status
Table 15: Novum IQ Large Volume Pump - Product Description
Table 16: PCA Pump - Product Status
Table 17: PCA Pump - Product Description
Table 18: PrismaLung+ - Product Status
Table 19: PrismaLung+ - Product Description
Table 20: PrismaLung+ - A Novel ECCO2R Device as a Lung Protective Measure in Hypercapnic Respiratory Failure: A Prospective Multicenter Trial
Table 21: PrismaLung+ - A Post-market Study of Performance and Safety of Low-flow Extracorporeal Carbon Dioxide Removal Using PrismaLung+ in Patients with Mild to Moderate Acute Respiratory Distress Syndrome
Table 22: Baxter Healthcare Corp, Joint Venture
Table 23: Glossary
List of Figures
Figure 1: Baxter Healthcare Corp Pipeline Products by Equipment Type
Figure 2: Baxter Healthcare Corp Pipeline Products by Development Stage
Figure 3: Baxter Healthcare Corp Ongoing Clinical Trials by Trial Status